BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30825832)

  • 1. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England.
    Mohamed Z; Al-Kurdi D; Nelson M; Shimakawa Y; Selvapatt N; Lacey J; Thursz MR; Lemoine M; Brown AS
    Int J Drug Policy; 2020 Jan; 75():102608. PubMed ID: 31759307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.
    Pallarés C; Carvalho-Gomes Â; Hontangas V; Conde I; Di Maira T; Aguilera V; Benlloch S; Berenguer M; López-Labrador FX
    J Clin Virol; 2018 May; 102():77-83. PubMed ID: 29525634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of rapid hepatitis C antibody assays in freshly collected whole blood, plasma and serum samples: A multicentre prospective study.
    Vetter BN; Ongarello S; Tyshkovskiy A; Alkhazashvili M; Chitadze N; Choun K; Sokkab A; De Weggheleire A; Vanroye F; Reipold EI
    PLoS One; 2020; 15(12):e0243040. PubMed ID: 33270716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
    Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
    BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection.
    Liu L; Zhang M; Hang L; Kong F; Yan H; Zhang Y; Feng X; Gao Y; Wang C; Ma H; Liu X; Zhan M; Pan Y; Xu H; Niu J
    Virol J; 2020 Jan; 17(1):14. PubMed ID: 32005264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection.
    Kant J; Möller B; Heyne R; Herber A; Böhm S; Maier M; Liebert UG; Mössner J; Berg T; Wiegand J
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):416-20. PubMed ID: 23211286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
    J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
    Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J
    J Hepatol; 2023 Sep; 79(3):635-644. PubMed ID: 37116714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new rapid test kit to detect hepatitis C virus infection.
    Kim MH; Kang SY; Lee WI
    J Virol Methods; 2013 Nov; 193(2):379-82. PubMed ID: 23871756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.
    Stockman LJ; Greer J; Holzmacher R; Dittmann B; Hoftiezer SA; Alsum LE; Prieve A; Westergaard RP; Guilfoyle SM; Vergeront JM
    Public Health Rep; 2016; 131(4):544-51. PubMed ID: 27453598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting.
    Hariri S; Sharafkhah M; Alavi M; Roshandel G; Fazel A; Amiriani T; Motamed-Gorji N; Bazazan A; Merat S; Poustchi H; Malekzadeh R
    Harm Reduct J; 2020 Aug; 17(1):56. PubMed ID: 32795371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
    Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
    Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings.
    Kosack CS; Nick S
    Trop Med Int Health; 2016 May; 21(5):603-9. PubMed ID: 26945920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.